Stay updated on TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page.

Latest updates to the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision updated to v3.5.0. The previous v3.4.3 revision was removed.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 in the study documents section.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.4.2 was added and the funding-status notice (and the v3.4.1 note) was removed. These are general site updates that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check49 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center status has been added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check57 days agoChange DetectedAdded a glossary toggle (Show glossary) and updated metadata: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, replacing the previous Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page header/footer; no study content or functionality changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page.